Female pattern hair loss (Androgenic alopecia) - Symptoms, Causes, Treatment & Prevention

Overview

Female pattern hair loss (FPHL), also known as androgenic alopecia in women, is a chronic, progressive thinning of the scalp hair that follows a characteristic pattern. Unlike the dramatic “bald spots” seen in men, women usually experience diffuse thinning over the crown while preserving the frontal hairline.

• Who it affects: Women of any ethnic background, most commonly after puberty.
• Prevalence: Approximately 10–13 % of women under 30 and up to 40 % of women by age 50 show signs of FPHL. The condition becomes increasingly common after menopause, affecting up to 70 % of post‑menopausal women.¹

Symptoms

Symptoms develop slowly over months to years and can vary in severity.

• Diffuse thinning over the crown (parietal area): Hair becomes finer and less dense, especially in the mid‑scalp region.
• Frontal hairline preservation: Unlike male‑pattern baldness, the hairline generally remains intact.
• Increased shedding: More hairs are noticed on pillows, in the shower, or on hairbrushes.
• Widening part: The part in the hair may become broader as density decreases.
• Hair texture change: Existing hairs become thinner, shorter, and softer.
• Scalp visibility: In severe cases, the scalp may become visible through the hair, especially under bright light.

Causes and Risk Factors

FPHL is multifactorial, involving genetics, hormonal influences, and environmental contributors.

Primary Causes

• Genetic predisposition: Polygenic inheritance; a family history of hair loss (in either gender) increases risk.
• Androgens: Although women have lower testosterone levels than men, dihydrotestosterone (DHT) can still mini‑aturize hair follicles, especially after menopause when the relative balance shifts.
• Hormonal changes: Pregnancy, postpartum period, oral contraceptives, and thyroid disorders can exacerbate shedding.

Risk Factors

• Age (risk rises after 40 years)
• Family history of androgenic alopecia
• Polycystic ovary syndrome (PCOS) or other hyperandrogenic conditions
• Thyroid disease (hypo‑ or hyper‑thyroidism)
• Iron‑deficiency anemia
• Severe emotional or physical stress
• Smoking (linked to reduced scalp blood flow)
• Medications that affect hormone levels (e.g., anabolic steroids, certain antihypertensives)

Diagnosis

Diagnosis is primarily clinical, but tests may be ordered to rule out other causes of hair loss.

Clinical Evaluation

• History taking: Duration of hair loss, menstrual and pregnancy history, family history, medication list, and lifestyle factors.
• Physical examination: Visual inspection of scalp pattern, hair pull test, and trichoscopic examination (magnified dermatoscopy).

Diagnostic Tests

• Blood work: CBC, ferritin, thyroid‑stimulating hormone (TSH), free T4, androgens (DHEAS, testosterone), and vitamin D levels to exclude anemia, thyroid disease, or nutritional deficiencies.²
• Scalp biopsy: Rarely needed; can distinguish androgenic alopecia from scarring alopecias.
• Trichogram or phototrichogram: Measures the proportion of hairs in the anagen (growth) vs. telogen (resting) phase.

Treatment Options

Treatment aims to halt progression, stimulate regrowth, and improve cosmetic appearance. Early intervention yields the best results.

Topical Medications

• Minoxidil 2–5 % solution or foam: The only FDA‑approved topical for women; promotes follicular blood flow and prolongs the anagen phase. Visible regrowth typically begins after 3–6 months of twice‑daily use.³
• Topical anti‑androgens (e.g., clascoterone): Emerging options under investigation; not yet widely available in the U.S.

Oral Medications

• Finasteride (1 mg) or Dutasteride: 5‑α‑reductase inhibitors reduce DHT levels. They are off‑label for women and contraindicated in pregnancy due to teratogenicity; used mainly in post‑menopausal women under specialist supervision.
• Spironolactone (50–200 mg daily): A potassium‑sparing diuretic with anti‑androgenic properties; commonly prescribed for women with hyperandrogenic features or PCOS.⁴
• Oral low‑dose oral contraceptives: Suppress ovarian androgen production and may improve hair density.
• Iron supplementation: If ferritin <30 ng/mL, oral iron can improve shedding.

Procedural Options

• Platelet‑Rich Plasma (PRP) injections: Autologous plasma concentrates growth factors; multiple sessions may yield modest density gains.
• Low‑Level Laser Therapy (LLLT): FDA‑cleared devices (comb, helmet, or cap) deliver red light to stimulate follicles.
• Hair transplantation: Follicular unit extraction (FUE) can be considered for stable, moderate‑to‑severe cases when donor hair is adequate.
• Scalp micropigmentation: Cosmetic tattooing that creates the illusion of denser hair; useful for patients who prefer non‑surgical options.

Lifestyle & Supportive Measures

• Gentle hair care: avoid tight ponytails, harsh chemicals, and excessive heat.
• Balanced diet rich in protein, iron, zinc, biotin, and omega‑3 fatty acids.
• Stress‑reduction techniques (mindfulness, yoga, adequate sleep).
• Regular follow‑up with a dermatologist or a trichologist to monitor response.

Living with Female Pattern Hair Loss (Androgenic Alopecia)

Hair loss can affect self‑esteem and emotional wellbeing. Practical strategies can help maintain quality of life.

Daily Management Tips

1. Choose volumizing haircuts: Layers, blunt bangs, or short bob cuts add the appearance of thickness.
2. Use lightweight, non‑oil‑based styling products: Mousses, volumizing powders, or dry shampoos can add lift without weighing hair down.
3. Consider hair‑fiber concealers: Microscopic keratin fibers cling to existing hair for a temporary, natural look.
4. Protect scalp from UV radiation: Wear hats or use sunscreen sprays if you spend prolonged time outdoors.
5. Maintain scalp hygiene: Gentle cleansing removes excess sebum that can clog follicles.
6. Track progress: Take standardized photos every 3 months to objectively assess treatment response.
7. Seek emotional support: Counseling, support groups, or online forums can mitigate the psychological impact.

Prevention

While genetics cannot be changed, certain habits can slow progression.

• Early detection: Recognize the first signs of thinning and start minoxidil or consult a clinician promptly.
• Maintain hormonal balance: Manage PCOS, thyroid disease, and menstrual irregularities with appropriate medical care.
• Optimal nutrition: Ensure adequate intake of iron, vitamin D, B‑complex vitamins, and protein.
• Avoid scalp trauma: Limit harsh chemical treatments, excessive heat, and tight hairstyles that cause traction alopecia.
• Quit smoking: Improves microcirculation to the scalp.

Complications

If left untreated, FPHL can lead to:

• Psychological distress: Anxiety, depression, and reduced self‑confidence.
• Progressive thinning: Once follicles become mini‑aturized, regrowth potential diminishes.
• Secondary scalp conditions: Over‑scratching or use of irritant styling products can cause dermatitis.

When to Seek Emergency Care

References

1. American Academy of Dermatology. “Hair Loss in Women.” 2023. aad.org.
2. National Institutes of Health. “Evaluation of Hair Loss.” NIH Clinical Guidelines, 2022.
3. Mayo Clinic. “Minoxidil (Topical) Use for Female Pattern Baldness.” 2024.
4. Cleveland Clinic. “Spironolactone for Hair Loss.” 2023.
5. World Health Organization. “Global Prevalence of Androgenic Alopecia.” WHO Report, 2021.